XML 83 R71.htm IDEA: XBRL DOCUMENT v3.20.2
Business Segments (Information on Operating and Reportable Segments) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Segment Reporting Information, Profit (Loss):        
Total revenues $ 237,422 $ 238,069 $ 466,816 $ 470,223
Cost of sales 99,761 101,318 195,287 199,405
Gross profit 137,661 136,751 271,529 270,818
Advertising and marketing 38,341 38,667 66,091 73,468
Contribution margin 99,320 98,084 205,438 197,350
Other operating expenses 26,417 28,736 52,416 56,516
Operating income 72,903 69,348 153,022 140,834
North American OTC Healthcare        
Segment Reporting Information, Profit (Loss):        
Total revenues 216,575 213,878 427,233 424,662
International OTC Healthcare        
Segment Reporting Information, Profit (Loss):        
Total revenues 20,847 24,191 39,583 45,561
Operating Segments | North American OTC Healthcare        
Segment Reporting Information, Profit (Loss):        
Total revenues 216,575 213,878 427,233 424,662
Cost of sales 91,069 92,931 178,896 181,742
Gross profit 125,506 120,947 248,337 242,920
Advertising and marketing 34,014 34,595 58,694 65,609
Contribution margin 91,492 86,352 189,643 177,311
Operating Segments | International OTC Healthcare        
Segment Reporting Information, Profit (Loss):        
Total revenues 20,847 24,191 39,583 45,561
Cost of sales 8,692 8,387 16,391 17,663
Gross profit 12,155 15,804 23,192 27,898
Advertising and marketing 4,327 4,072 7,397 7,859
Contribution margin 7,828 11,732 15,795 20,039
Intersegment Eliminations | North American OTC Healthcare        
Segment Reporting Information, Profit (Loss):        
Total revenues $ 600 $ 800 $ 1,600 $ 1,600